S. Pirruccello

发表

Systemic administration of a phosphorothioate oligonucleotide with a sequence complementary to p53 for acute myelogenous leukemia and myelodysplastic syndrome: initial results of a phase I trial.

P. Iversen, G. Zon, R. Ruddon, 1993, Antisense research and development.

Pharmacokinetics and in vivo effects of a six-base phosphorothioate oligodeoxynucleotide with anticancer and hematopoietic activities in swine.

P. Iversen, J. Jackson, M. Bishop, 2000, Journal of hematotherapy & stem cell research.

Immunologic attributes of cytokine mobilized peripheral blood stem cells and recovery following transplantation.

J. Jackson, J. Talmadge, M. Arneson, 1996, Bone marrow transplantation.

Oligonucleotides complementary to c-myb messenger RNA inhibit growth and induce apoptosis in human Burkitt lymphoma cells.

P. Iversen, M. Bishop, J. Sharp, 1996, International journal of oncology.

Functional and phenotypic characterization of human peripheral blood stem cell harvests: a comparative analysis of cells from consecutive collections.

J. Jackson, S. Joshi, A. Kessinger, 1995, Blood.

Antitumor activity of human umbilical cord blood cells: A comparative analysis with peripheral blood and bone marrow cells.

M. Bishop, S. Joshi, A. Kessinger, 1998, International journal of oncology.

Comparison of ISHAGE protocol CD34 cell enumeration with a lineage negative backgating technique.

J. Jackson, M. Bishop, A. Kessinger, 1999, Cytotherapy.

Lymphocyte reconstitution after allogeneic blood stem cell transplantation for hematologic malignancies

M. Bishop, J. Armitage, A. Kessinger, 1998, Bone Marrow Transplantation.

Allogeneic-blood stem-cell collection following mobilization with low-dose granulocyte colony-stimulating factor.

P. Bierman, J. Jackson, M. Bishop, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A hexameric phosphorothioate oligonucleotide telomerase inhibitor arrests growth of Burkitt's lymphoma cells in vitro and in vivo.

P. Iversen, J. Jackson, T. Page, 1997, Toxicology and applied pharmacology.

Effects of BCR-ABL antisense oligonucleotides (AS-ODN) on human chronic myeloid leukemic cells: AS-ODN as effective purging agents.

W. Chan, W. Sanger, P. Iversen, 1995, Leukemia & lymphoma.

fungoides/Sezary syndrome: a potential marker for circulating Sezary Differential expression of CD24-related epitopes in mycosis

Lang, S. Pirruccello, 2013 .

Molecular weight characterization of beta-D-glucocerebrosidase in mononuclear white blood cells in Gaucher's disease.

E. Ginns, R. Brady, J. Barranger, 1984, Biochemical medicine.

Mutations of glucocerebrosidase: discrimination of neurologic and non-neurologic phenotypes of Gaucher disease.

E. Ginns, R. Brady, J. Barranger, 1982, Proceedings of the National Academy of Sciences of the United States of America.

c-myc antisense oligodeoxyribonucleotides inhibit proliferation of non-small cell lung cancer.

L. Smith, S. Pirruccello, L. Robinson, 1995, The Annals of thoracic surgery.

Selective cytotoxicity to human leukemic myeloblasts produced by oligodeoxyribonucleotide phosphorothioates complementary to p53 nucleotide sequences.

P. Iversen, R. Ruddon, E. Bayever, 1994, Leukemia & lymphoma.